sgx nifty futures contract specifications

Visit the link: https://www.nseindia.com/trade/all-member-faqs, YOU ARE ON THE NEW NSE WEBSITE, ACCESS THE OLD WEBSITE ON THE URL, . ;2.Based on my knowledge,this report does not contain any untrue statement of a material fact or omit to state a material fact necessary tomake the statements made,in light of the circumstances under which such statements were made,not misleading with respect to theperiod covered by this report;3.Based on my knowledge,the financial statements,and other financial information included in this report,fairly present in all materialrespects the financial condition,results of operations and cash flows of the registrant as of,and for,the periods presented in this report;4.The registrants other certifying officer(s)and I are responsible for establishing and maintaining disclosure controls and procedures(asdefined in Exchange Act Rules 13a-15(e)and 15d-15(e)and internal control over financial reporting(as defined in Exchange Act Rules13a-15(f)and 15d-15(f)for the registrant and have:a)Designed such disclosure controls and procedures,or caused such disclosure controls and procedures to be designed under oursupervision,to ensure that material information relating to the registrant,including its consolidated subsidiaries,is made known tous by others within those entities,particularly during the period in which this report is being prepared;b)Designed such internal control over financial reporting,or caused such internal control over financial reporting to be designedunder our supervision,to provide reasonable assurance regarding the reliability of financial reporting and the preparation offinancial statements for external purposes in accordance with generally accepted accounting principles;c)Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures,as of the end of the period covered by this report based onsuch evaluation;andd)Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrantsmost recent fiscal quarter(the registrants fourth fiscal quarter in the case of an annual report)that has materially affected,or isreasonably likely to materially affect,the registrants internal control over financial reporting;and5.The registrants other certifying officer(s)and I have disclosed,based on our most recent evaluation of internal control over financialreporting,to the registrants auditors and the audit committee of the registrants board of directors(or persons performing the equivalentfunctions):a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting whichare reasonably likely to adversely affect the registrants ability to record,process,summarize and report financial information;andb)Any fraud,whether or not material,that involves management or other employees who have a significant role in the registrantsinternal control over financial reporting.Date:November 21,2022/s/Edward P.Decker Edward P.DeckerChair,President and Chief Executive OfficerExhibit 31.2CERTIFICATIONI,Richard V.McPhail,certify that:1.I have reviewed this quarterly report on Form 10-Q of The Home Depot,Inc. The security descriptor for the futures contracts is: Futures contracts are available on 189 securities stipulated by the Securities & Exchange Board of India (SEBI). *In a few cases,though the policies do not directly mention about a particular incentive,an indication of indirect initiatives has been consideredSource:Respective state government websites;Invest India website updated as of November 2022;CBRE Research,Q1 2023State-level Policies are Additional Investment MagnetsFigure 3.2:Key state-level policies for the LS sector in India 11)%Haryana Pharmaceutical Policy,2019Uttar Pradesh Pharmaceutical Industry Policy,2018Rajasthan MedTech and Bulk Drug Policy,2021Karnataka Biotechnology Policy,2017Gujarat Biotechnology Policy,2022 Telangana Life Sciences Policy,2015Odisha Biotechnology Policy,2018Tamil Nadu Life Sciences Policy,202211289647352Himachal PradeshMadhya PradeshMaharashtraAndhra PradeshLEGENDLand-related incentivesInfrastructure developmentCapital subsidies/capital interest subsidiesStamp duty exemptionsTax benefitsSingle-window clearance/ease of approvalsStates with dedicated LS policiesExisting medical devices clusters3 Bulk Drug Parks proposedHimachal Pradesh,Gujarat and Andhra Pradesh4 Medical Devices Parks proposed Tamil Nadu,Madhya Pradesh,Uttar Pradesh,Himachal PradeshPRIMARY LOCATIONS 1.Hyderabad2.BangaloreSECONDARY LOCATIONS 1.Mumbai2.Pune3.Delhi-NCR4.Chennai5.Ahmedabad6.Vadodara7.Visakhapatnam8.Valsad9.Ankleshwar11 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentChapter 4LS Real Estate Clusters in India12 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentLS company portfolios typically consist of four major components,namely R&D laboratories,logistics facilities(including cold storage),manufacturing facilities and corporate offices,as detailed below:Key Components of LS Real Estate PortfoliosBiotechnology R&DGenetic engineeringCell engineeringEnzyme engineeringFermentation engineeringProtein engineeringRaw materialsPlasmaCell culture geneAntibodies and enzymesLow serum medium AntigenBiomedical manufacturingGenetically engineered drugVaccinesBlood productsDiagnostic reagentLogistics and salesDistributors/3PL playersLogisticsWholesalersConsumersR&D labsResearch organisationsPharmaceutical companiesPharmaceutical companiesUniversitiesHospitalsDistributors/3PL firmsPharmacies/Retail shopsOficesLS parksSmall-sized manufacturing plantsLarge-sized manufacturing plantsOficesLS parksPharmaceutical companiesPharmaceutical companiesResearch organisationsLS parksOficesLS parksIndustrial parksIndustrial parksOther chemical raw materialsCold ChainLogisticsIndustrial parksSource:CBRE Research,Q1 2023Real estate asset types that house LS companies:Components of LS company portfolios:LS parkIndustrial parkOfficeRetailR&D laboratoriesLogistics facilitiesLarge-sized manufacturing plantsSmall-sized manufacturing plants13 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentPharmaceuticals is a highly regulated industry and entails numerous regulatory approvals,including the registration of manufacturing plants and Good Manufacturing Practices(GMP)certifications.An analysis of the WHO-GMP*certified pharmaceutical manufacturing plants in the country revealed that as of 2019,Gujarat housed the highest number of WHO-GMP certified pharma manufacturing plants followed by Maharashtra,Himachal Pradesh and Telangana.Further,Uttarakhand,Tamil Nadu,Karnataka and Andhra Pradesh are also major manufacturing hubs(refer Figure 4.1).Moreover,India ranks second globally in terms of the number of US FDA-certified plants located outside the US,closely following China(refer Figure 4.2).LS Manufacturing Well Supported by Pharmaceutical Clusters in IndiaFigure 4.1:Geographical distribution of WHO-GMP-certified plants in India(as of 2019)Figure 4.2:Percentage of US FDA-certified plants located outside the US(as of May 2022)HimachalPradeshUttarakhandMaharashtraTelanganaAndhraPradeshTamil NaduKarnatakaGujaratLowestHighest19%8%5%5%4%4%4%3%3%3%2%2%2%Source:Central Drugs Standard Control Organization(CDSCO),2019;CBRE Research,Q1 2023*World Health Organization Good Manufacturing PracticesSource:US Food&Drug Administration,May 2022;CBRE Research,Q1 2023ChinaIndiaSouth KoreaCanadaFranceGermanyItalyMexicoUnited KingdomJapanSpainSwitzerlandIrelandTaiwanOthers14 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentTelangana leads with the highest number of US FDA-certified plants,followed by Maharashtra,Gujarat,Andhra Pradesh,Karnataka and Tamil Nadu.Other states with a sizeable presence include Madhya Pradesh and Himachal Pradesh.A further analysis of the type of operations revealed that while Gujarat is the topmost state for general manufacturing,Telangana is the leading state for analysis and API manufacturing.Telangana,Maharashtra and Gujarat are the Key Export ClustersFig 4.3:Distribution of US-FDA certified plants in India(as of May 2022)Fig 4.4:Distribution of US-FDA certified plants by type of operations(as of May 2022)HimachalPradeshMaharashtraTelanganaAndhraPradeshTamil NaduKarnatakaGujaratLowestHighestMadhya PradeshSource:US Food&Drug Administration,May 2022;CBRE Research,Q1 2023*indicates production of finished pharmaceutical products *indicates production of an active ingredient in any pharmaceutical productSource:US Food&Drug Administration,May 2022;CBRE Research,Q1 2023GujaratMaharashtraTelanganaKarnatakaOthersTelanganaAndhra PradeshMaharashtraKarnatakaOthers22%8%#%Manufacturing*API Manufacturing*15 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentIndia has about nine biotechnology clusters at various stages of development,located in Karnataka,Telangana,Tamil Nadu,Gujarat,Uttar Pradesh,Kerala,Chhattisgarh and Jammu&Kashmir.Below is a snapshot of select biotechnology clusters in the country along with an indication of the availability of real estate facilities such as office spaces,manufacturing units,R&D lab spaces and logistics&cold storage facilities.Source:Department of Biotechnology,GoI;CBRE Research,Q1 2023*PPP Public Private Partnership;*for R&D lab space LS Parks Facilitate Office,Manufacturing,R&D and Logistics RequirementsFigure 4.5:Key LS Parks in India11)%CityLucknowLS clusterBiotech Park,LucknowYear of setup2002CategoryEstablished clusterOwnershipGovernmentCityVadodaraLS clusterSavli Biotech ParkYear of setup2007CategoryEstablished clusterOwnershipGovernmentCityChennaiLS clusterTICEL Bio ParkYear of setup2004CategoryEstablished clusterOwnershipGovernmentCityBangaloreLS clusterBengaluru LS ParkYear of setup2022CategoryEmerging clusterOwnershipA PPP*between the Government of Karnataka and private entity Labzone CorporationOther key clustersSyngene Park,BIOCON CampusCityHyderabadLS clusterGenome ValleyYear of setup1999CategoryEstablished clusterOwnershipGovernment land allotments to various private companiesOther key clustersMedical Device Park at Sultanpur,Hyderabad Pharma CityUttar PradeshTamil NaduTelanganaKarnatakaGujaratOffice spacePrimary marketsSecondary marketsManufacturing unitsR&D lab spaceLogistics&cold storage facilities16 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentLeading LS companies in India prefer to operate from large-scale parks that can meet both their office and R&D needs.Startups and MSMEs are also increasingly opting to locate themselves in parks with a clear industrial positioning and abundant R&D resources.Thus,site selection plays an important role for the successful functioning of any LS park catering to various occupier requirements.What do Occupiers Look for in LS Parks?Figure 4.6:Site selection strategy for LS clustersHigh industry concentrationPresence of upstream and downstream industriesHigh quality clinical resources and laboratoriesSupportive central&state policiesPromotion of industrial clustersTransport:Last-mile connectivity,shuttle services,public transportation and parking spacesEnvironment:Green/open spaces and amenitiesCore:Ofice spaces and R&D labsOthers:Exhibition centres,conference rooms,leisure spacesIndustrial land with environmental clearances and a non-contentious titleCompliance with general requirements and building technical codes for biosafe laboratoriesDedicated space for biohazard disposal solutionsSingle storey factory with cleanroomStrict security to prevent theft or leakage of R&D data5.0 m floor height(including space for R&D equipment installation)Electrical Supply:200-650 W/sq.m.Floor Loading:500 1,500 kg/sq.m.Ceiling Bearing:to accommodate air handling unit(AHU)LocationPolicyAmenitiesFunctionLand TitleProperty TypeSpecifications*Note Specifications can vary basis the type of facility(drug substance/drug product/an Oral Solid Dosage(OSD)facility)Source:CBREs Shanghai Pharmaceutical&LS Industry Report,2021;CBRE Research,Q1 202317 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentChapter 5LS Real Estate Trends in India18 CBRE RESEARCH2023 CBRE,INC.Life Sciences in India The Sector of TomorrowIntelligent InvestmentSustained Leasing Activity by LS Firms over the Last Two Years;Healthcare Companies a Key DriverFigure 6.1:Annual space take-up by LS companies(2019-2022)Rank indicates the LS sector position in overall pan-India leasing as compared to other sectorsFigure 6.2:Sub-sector-wise leasing by LS companies(2019-2022)0%1%2%3%4%5%6%7%0.00.51.01.52.02.53.020192020Rank 8Rank 7Rank 6Rank 620212022(%share)(in million sq.ft. New contracts with new strike prices for existing expiration date are introduced for trading on the next working day based on the previous days underlying close values, as and when required. Contract size. )CSPsoffer high bandwidth,optimized performance,compliance with local regulations,and robust disasterrecovery.And because edge-computing use cases are on the rise,CSPs are extending their coveragecloser to the data sources. Futures contracts are closely related to the settlement price of the Nifty on the NSE. THE OLD WEBSITE SHALL BE DISCONTINUED W.E.F APRIL 1, 2023. The underlying symbol denotes the underlying security in the Capital Market (equities) segment of the Exchange, Expiry date identifies the date of expiry of the contract, Strike Price: Strike price for the contract. The MSCI Taiwan Index is designed to measure the performance of the large and mid-cap segments of the Taiwan market, covering about 85% of the free float-adjusted market capitalisation in Taiwan. Exchange has published Member Help Guide and new FAQs for Access to Markets. )We have identified eight emerging technologies(beyond solar and wind)that,with the help of marketshaping,can get us to net zero:electric vehicles,clean steel,green cement,sustainable aviation fuel,direct air capture,low-carbon hydrogen,long-duration energy storage,and advanced nuclear small-modular reactors. A new contract is introduced on the trading day following the expiry of the near month contract. )2023 Boston Consulting Group5At maturity,and if adopted at scale,these technologies could collectively enable about 22 gigatonnesper year in global emissions abatement and fuel a cumulative global market size of$45 to$60 trillionthrough 2050.But these emerging climate technologies will not achieve widespread adoption until we remove thefollowing barriers:Unattractive Risk-Return Profile for Institutional Investors.Without proper incentives,organizationscan be reluctant to invest in unproven technologies under development given the risk that thetechnologies may fail.Unproven Markets.When introducing a new product,companies must prove that its safe,reliable,affordable,and scalableand prove to investors it is commercially viable to raise capital.Subscale Investments for Projects.Even promising projects can languish for years in the valley ofdeath as they seek additional funding from governments and other sources to scale up.Insufficient Value Proposition for Corporate Buyers.Some climate technologies will come at a costpremium as they scale without additional functional benefits;companies must be willing to paythat differential.2023 Boston Consulting Group6The good news is that these barriers can be overcome with deliberate actions.In the US,for example,the 2022 Inflation Reduction Act provides both production and investment tax incentives for keyclimate technologies,including incentives to ramp up carbon-capture facilities and boost greenhydrogen production.The goal is to improve the overall risk-return profile and spur investments in theinnovative technologies most needed to meet net-zero goals.These incentives have spurred action notjust in the US but globally,with many major economies developing similar plans to support the marketfor climate technologies.Market-shaping mechanisms like these can dramatically shi the economicviability of green energy and climate technology.How to Drive New Forms of InvestmentCompanies and investors are experimenting with new mechanisms to accelerate the development andscaling of climate technologies.Here are some of the most promising ones being used today.Mobilize capital through innovative finance and send clear demand signals.Companies canaccelerate the development and deployment of climate technologies by mobilizing capital through avariety of mechanisms,including advance market commitments,concessional capital,oakeagreements,volume guarantees,and coalitions.These mechanisms not only provide alternativefunding sources beyond institutional investors to help companies cross the valley of death but alsosupport mitigation beyond companies value chains and help address some of the imbalance thatexists today between net zero targets and available offset mechanisms.Advance Market Commitments(AMCs).With AMCs,a pool of money is allocated to purchase largequantities of a product at established prices,which incentivizes large-scale development anddeployment at an affordable price.Example:Frontier Climate has committed$925 million to fund the development of carbonremoval technologies between 2022 and 2030.Frontiers AMCs send a strong demand signalwithout favoring any particular technology.Similarly,the Carbon Removal Alliance,anindustry group of 20-plus members,is working to advance policies that support permanentcarbon removal technologies.Concessional Capital.Concessional capital aims to benefit the greater good and catalyze additionalthird-party investment,making it a more patient and risk-tolerant investment.Example:Breakthrough Energy Catalyst has raised over$1.5 billion of concessional capitalfrom philanthropies,governments,and companies to support large-scale demonstrations ofcritical climate technologies.Oakes,Volume Guarantees,and Pooled Procurement.These mechanisms deploy capital when atechnology is available for purchase,reducing the financial risk companies face when scaling up 2023 Boston Consulting Group7Advocate for and implement beneficial policy mechanisms.Companies can also work withgovernments and regulators to spur investment in promising technologies so they can scale up andbecome more affordable,which in turn incentivizes financial institutions and buyers to invest in thetechnology.Here are just a few examples:Investment is flowing.In 2021,venture capital and private equity in climate technologies exceeded$50billion,and in 2022,the US Inflation Reduction Act devoted approximately$400 billion in funding toaccelerate climate tech.Now is the time for corporations and financial institutions to execute market-production.Oakes and volume guarantees can be purchased in conjunction with othercompanies(using a mechanism called pooled procurement),allowing buyers to gain purchasingpower and secure supply.Example:The Clean Energy Buyers Association deploys clean energy and tracks utility-scaledeals in the procurement of renewables,where the deals serve as customer-led volumeguarantees for renewables providers.Coalitions can send a clear signal that market demand exists for climate technologies.Example:As part of First Movers Coalition,50 companies committed to decarbonizingseven hard-to-abate industrial sectors by purchasing clean energy technologies.This includesadvance purchasing a portion of materials and transportation needed from suppliers usingnear-zero or zero-carbon solutions.Permitting.Permitting and reviews can be a hurdle that slows deployment of many climatetechnologies.The direct and indirect costs of permitting can account for 30%of residential solarinstallation costs and the average wait time for installation has doubled from 2005 to 2020.Incentives.In the United States,the 2022 Inflation Reduction Act implemented an$85 per toncredit for permanent geological sequestration of CO2 and a 60%investment tax credit for newsolar projects,among many others.Climate Auctions.More than 100 countries are using auction-based approaches to subsidizerenewable energy,and many have achieved renewable energy prices that are lower thantraditional power sources.Feed-in Tariffs.With agreement from the regulator,in 2013,Dominion Energy created a feed-intariff for residential and commercial solar photovoltaic generators in the United States.Participants receive 15 cents per kilowatt hour for all solar photovoltaic-generated electricityprovided to the grid,which has helped bring 2,200 megawatts of solar into operation in ten statesenough energy to power about 550,000 homes at peak output.2023 Boston Consulting Group8shaping activities to further legitimize markets,advance climate technologies toward large-scalecommercialization,and gain benefits and competitive advantage in the process.Next Steps for Developing a Market-Shaping StrategyEvery organization can take steps to dramatically accelerate adoption of climate technologies withinand beyond their value chain.For companies and financial institutions that wish to participate in market shaping and reap itsbenefits,there are a range of options to consider.For example,companies can reduce carbonemissions throughout their value chain,work with industry partners to increase the scale of existinginitiatives,spearhead market-shaping initiatives,and advocate for policies that are favorable toclimate technology adoption.Market shaping is a win-win for companies,allowing them to secure supply,meetclimate goals,and increase internal know-how on essential technologies.Financial institutions can incorporate climate metrics into their investment strategy,encourageportfolio companies to disclose climate data,launch sustainability-linked instruments,and joinmarket-leading efforts to fund commercial-scale green technologies.While financial institutions arefacing scrutiny around climate initiatives,the benefits of climate investments will continue to grow overtime,creating a singular opportunity to shape the market.The slideshow lays out the most important actions companies and financial institutions can take nowto shape the market for emerging climate technologies and speed progress toward globaldecarbonization.2023 Boston Consulting Group9If we want to achieve global net zero,we cant allow climate technologies to evolve at their currentpace.They will take far too long to scale.To move the market faster,we need to encourage new waysof investing.Market shaping is a win-win for companies,allowing them to secure supply,meet climate goals,andincrease internal know-how on essential technologies.By aligning private capital,public capital,andpublic policy,market shaping can play a key role in ensuring climate technologies gain the traction theyneed to scaleand ultimately transform our world.The authors thank BCGs Connor Sendel and Habib Azarabadi for their contributions to this article.2023 Boston Consulting Group10AuthorsThomas BakerMANAGING DIRECTOR&PARTNERSan Francisco-Bay AreaBahar CarrollPROJECT LEADERSeattleGreg FischerPARTNER AND DIRECTORLondonKaran MistryPARTNERLos AngelesPaulina Ponce de Len BaridMANAGING DIRECTOR&PARTNERSan Francisco-Bay AreaTina Zuzek-ArdenMANAGING DIRECTOR&PARTNERWashington,DC ABOUT BOSTON CONSULTING GROUP1From Clean Tech 1.0 to Climate Tech 2.0:A New Era of Investment Opportunities,B CapitalGroup,January 17,2023,https:/ the Clean Industrial Revolution,Breakthrough Energy,October 29,2021,https:/breakthroughenergy.org/news/financing-the-clean-industrial-revolution/.2023 Boston Consulting Group11Boston Consulting Group partners with leaders in business and society to tackle their most importantchallenges and capture their greatest opportunities.BCG was the pioneer in business strategy when it wasfounded in 1963.Today,we work closely with clients to embrace a transformational approach aimed atbenefiting all stakeholdersempowering organizations to grow,build sustainable competitive advantage,and drive positive societal impact.Our diverse,global teams bring deep industry and functional expertise and a range of perspectives thatquestion the status quo and spark change.BCG delivers solutions through leading-edge managementconsulting,technology and design,and corporate and digital ventures.We work in a uniquely collaborativemodel across the firm and throughout all levels of the client organization,fueled by the goal of helping ourclients thrive and enabling them to make the world a better place.Boston Consulting Group 2023.All rights reserved.For information or permission to reprint,please contact BCG at .To find the latestBCG content and register to receive e-alerts on this topic or others,please visit .Follow BostonConsulting Group on Facebook and Twitter.

Mary Olivia Cushing Coleman Obituary, Realization Of Tumbang Preso, Old Hollywood Bridal Hair, Steven Universe The Return 2022 Release Date, Articles S